Coherus Oncology, Inc.
CHRS
Revenue
123.86M
▲12.17M▲10.90%
3 Months ChangeAssets
258.34M
▼-258.18M▼-49.98%
3 Months ChangeLiabilities
197.33M
▼-231.42M▼-53.98%
3 Months ChangeFree Cash Flow
-68.88M
▼-14.22M▼-26.02%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-03-09
Form 8-K
ID: 0001104659-26-025293
2026-02-17
Form 8-K
ID: 0001104659-26-016378
2026-02-04
Form 8-K
ID: 0001104659-26-010065
2026-01-23
Form 8-K
ID: 0001104659-26-006307
2026-01-13
Form 8-K
ID: 0001104659-26-003117
2025-11-13
Form 8-K
ID: 0001104659-25-111484
2025-11-06
Form 10-Q
ID: 0001104659-25-107852
2025-11-06
Form 8-K
ID: 0001104659-25-107780
2025-09-08
Form 8-K
ID: 0001558370-25-011911
2025-08-07
Form 10-Q
ID: 0001558370-25-010803